The health sector is vulnerable to compliance risks because of the complexity of its value chain and the size of the financial flows in the sector. Under a mandate from Norges Bank Investment Management, the Basel Institute on Governance has facilitated the development of a set of indicators that healthcare companies may wish to consider when reporting on the effectiveness of their anti-corruption efforts to external stakeholders in order to build trust with stakeholders, to mitigate reputational risk and to identify best practices.

More information: https://baselgovernance.org/publications/measuring-effectiveness-anti-corruption-programmes-indicators-company-reporting